The Oslo Stan vs Lactate Observational Study
1 other identifier
observational
694
1 country
1
Brief Summary
The main aim of the study is to compare the clinical performance of two adjunctive methods to CTG in intrapartum fetal monitoring: FBS with measurement of scalp lactate and ST analysis of the fetal ECG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedFirst Posted
Study publicly available on registry
March 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedDecember 4, 2023
December 1, 2023
1.3 years
December 12, 2019
December 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Is fetal hypoxia (defined as arterial umbilical cord pH < 7,1 postpartum) superiorly identified by fetal scalp blood sampling (lactate) or ST analysis of fetal ECG
1. Compare the diagnostic capability of both methods to identify fetuses at risk of hypoxia (i.e.umbilical artery blood pH ≤7.1) 2. Compare FBS lactate with STAN in order to identify the superior method to avoid cord-blood acidosis at birth (i.e.umbilical artery blood pH \>7.1) 3. Compare the true negative alerts from both methods, specificity
2019-2022
Is cord blood acidosis, measured as pH in the umbilical artery postpartum affected by the "Decision-to-delivery interval" measured in minutes from Lactate warning until delivery.
To assess the effect of increasing time interval from the objective warning of intrapartum fetal hypoxia with fetal scalp lactate ≥ 4.8mmol/l to the end of operative delivery on the percentage of moderate cord-blood acidosis at birth (i.e., umbilical artery blood pH ≤ 7.1)
2019-2022
Study Arms (2)
Fetus in labour at risk of acedimia
The Group of patients studied are fetuses in labour at risk of hypoxia with internal fetal monitoring and scalp lactate bloodsamples ( standard monitoring).
Fetus in labour at risk of acedemia with STAN analysis
Same group of fetuses in labour at risk of hypoxia with internal fetal monitoring and STAN analysis(ST waveform analysis of the fetal electrocardiogram, opened after study inclusion finished)
Interventions
The CTG will be analysed by an expert group additional to the standard procedure that have been done in Labour already. The STAN analysis will be decrypted/ demasked anonymously by the Company producing these machines.
Eligibility Criteria
Women in labour who are monitored with CTG and FBS scalp lactate. CTG monitoring is achieved by an internal scalp electrode combined with a pressure-sensitive external contraction transducer. FBS is performed at the decision of the obstetrician. Capillary blood is obtained from the fetal head and analyzed with a bed-side test (Lactate Pro). The monitoring procedures described above are identical with the current clinical routine at the department. The department utilizes S31 fetal monitors (Neoventa Medical AB©, Sweden), which are equipped with the hard and software tool for ST analysis. Once the scalp electrode is attached, ST analysis will be performed and recorded continuously. ST information is blinded in labor, i.e. clinical management will only be based on CTG and FBS if indicated.
You may qualify if:
- Singleton pregnancy
- Cephalic presentation
- Gestational age ≥36+0 weeks at delivery
- Presence of antpartum or intrapartum risk factors for fetal hypoxia according to Norwegian guidelines and therefore indication for electronic fetal monitoring with scalp electrode .
You may not qualify if:
- Multiple pregnancies
- Breech presentation
- Gestational age \< 36+0 weeks
- Contraindications for placement of a scalp electrode (HIV or HBV or HCV pos)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- Haukeland University Hospitalcollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0424, Norway
Related Publications (3)
Berge MB, Kessler J, Staff AC, Jacobsen AF. The diagnostic accuracy of different fetal blood sample lactate cutoffs in labor, utilizing the StatStrip Xpress(R) lactate-meter: A population-based observational study. Acta Obstet Gynecol Scand. 2025 Aug;104(8):1496-1504. doi: 10.1111/aogs.15140. Epub 2025 Apr 30.
PMID: 40304212DERIVEDBerge MB, Jacobsen AF, Yli BM, Staff AC, Gunnes N, Falk RS, Helgadottir LB, Kessler J. A direct comparison of the diagnostic accuracy of ST segment analysis (STAN) and fetal scalp blood sample lactate: A population-based observational study. Eur J Obstet Gynecol Reprod Biol. 2025 Apr 17;308:147-152. doi: 10.1016/j.ejogrb.2025.03.002. Epub 2025 Mar 3.
PMID: 40054097DERIVEDBerge MB, Kessler J, Yli BM, Staff AC, Gunnes N, Jacobsen AF. Neonatal outcomes associated with time from a high fetal blood lactate concentration to operative delivery. Acta Obstet Gynecol Scand. 2023 Aug;102(8):1106-1114. doi: 10.1111/aogs.14597. Epub 2023 Jun 7.
PMID: 37287317DERIVED
Study Officials
- STUDY DIRECTOR
Jacobsen F Anne Flem, MD, PhD
OUH
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Consultant, dpt of Obstetrics, Prof II University of Oslo
Study Record Dates
First Submitted
December 12, 2019
First Posted
March 3, 2021
Study Start
September 1, 2018
Primary Completion
December 31, 2019
Study Completion
October 31, 2023
Last Updated
December 4, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share